AU2020388398A1 - Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug - Google Patents

Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug Download PDF

Info

Publication number
AU2020388398A1
AU2020388398A1 AU2020388398A AU2020388398A AU2020388398A1 AU 2020388398 A1 AU2020388398 A1 AU 2020388398A1 AU 2020388398 A AU2020388398 A AU 2020388398A AU 2020388398 A AU2020388398 A AU 2020388398A AU 2020388398 A1 AU2020388398 A1 AU 2020388398A1
Authority
AU
Australia
Prior art keywords
healthcare
patient
enrollment
information
management database
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020388398A
Other languages
English (en)
Inventor
Daniel Adelman
Adrian Dana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU2020388398A1 publication Critical patent/AU2020388398A1/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Databases & Information Systems (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2020388398A 2019-11-20 2020-11-19 Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug Pending AU2020388398A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962938180P 2019-11-20 2019-11-20
US62/938,180 2019-11-20
US202063056492P 2020-07-24 2020-07-24
US63/056,492 2020-07-24
PCT/US2020/061362 WO2021102186A1 (en) 2019-11-20 2020-11-19 Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug

Publications (1)

Publication Number Publication Date
AU2020388398A1 true AU2020388398A1 (en) 2022-04-21

Family

ID=75909665

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020388398A Pending AU2020388398A1 (en) 2019-11-20 2020-11-19 Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug

Country Status (8)

Country Link
US (2) US20220415464A1 (https=)
EP (1) EP4061753A4 (https=)
JP (1) JP2023502423A (https=)
CN (1) CN114981191B (https=)
AU (1) AU2020388398A1 (https=)
BR (1) BR112022009664A2 (https=)
CA (1) CA3162233A1 (https=)
WO (1) WO2021102186A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022003604A1 (en) 2020-07-01 2022-01-06 Société des Produits Nestlé S. A. Determining medical staffing for oral immunotherapy
US12100510B2 (en) 2022-10-10 2024-09-24 CareMetx, LLC System and method for enrollment into patient service programs

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797515A (en) * 1995-10-18 1998-08-25 Adds, Inc. Method for controlling a drug dispensing system
US20090019552A1 (en) * 2000-03-15 2009-01-15 Mclaughlin Mark R Healthcare Medical Information Management System
US7668730B2 (en) * 2002-12-17 2010-02-23 JPI Commercial, LLC. Sensitive drug distribution system and method
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
CA2616511C (en) * 2007-07-06 2017-11-07 Catalyst Healthcare Ltd. Medication dose administration and inventory management
US8386274B1 (en) * 2008-09-17 2013-02-26 Mckesson Financial Holdings Limited Systems and methods for a prescription safety network utilizing eligibility verification transactions
WO2010104841A2 (en) * 2009-03-09 2010-09-16 Celgene Corporation Device for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated and methods for use thereof
US8392219B1 (en) * 2010-05-10 2013-03-05 Mckesson Financial Holdings Limited Systems and methods for streamlined patient enrollment for one or more healthcare programs
CA2807949C (en) * 2010-08-13 2022-10-25 Intellimedicine, Inc. System and methods for the production of personalized drug products
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
EP2617296A1 (en) * 2012-01-19 2013-07-24 Nestec S.A. A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms
US20130292294A1 (en) * 2012-05-03 2013-11-07 Brandon J. Wilson Allergy emergency kit
CN109125283A (zh) * 2013-03-14 2019-01-04 艾慕恩治疗公司 用于口服脱敏的花生制剂的制备
WO2014159609A1 (en) * 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
KR102233251B1 (ko) * 2013-04-03 2021-03-26 엔-폴드 엘엘씨 신규 나노입자 조성물
TWI633891B (zh) * 2013-06-04 2018-09-01 再生元醫藥公司 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法
US20170021010A1 (en) * 2015-07-21 2017-01-26 David Phillip ERSTEIN Allergy preventing dosage controlled food packets
EP3371770A4 (en) * 2015-11-04 2019-04-24 Bayer Healthcare LLC BARCODE DATABASE AND SOFTWARE UPGRADING SYSTEM
EP3440579A4 (en) * 2015-11-24 2020-03-25 Klaritos, Inc. INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
US20230190645A1 (en) * 2017-12-06 2023-06-22 Prollergy Corporation Composition and method for reducing allergic response

Also Published As

Publication number Publication date
US20210151155A1 (en) 2021-05-20
US20220415464A1 (en) 2022-12-29
CN114981191A (zh) 2022-08-30
CN114981191B (zh) 2025-08-15
JP2023502423A (ja) 2023-01-24
EP4061753A4 (en) 2023-12-13
EP4061753A1 (en) 2022-09-28
BR112022009664A2 (pt) 2022-08-16
WO2021102186A1 (en) 2021-05-27
CA3162233A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
Santos et al. EAACI guidelines on the management of IgE‐mediated food allergy
Blakey et al. Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand
US20190139635A1 (en) Methods of regulating access to qsymia to mitigate potential drug-associated risks
Beasley et al. Asthma and Respiratory Foundation NZ Adolescent and Adult Asthma Guidelines, 2020: A Quick Reference Guide
Kim et al. Omalizumab: Practical considerations regarding the risk of anaphylaxis
Nypaver et al. Preconception care: Improving the health of women and families
CN1425167A (zh) 给患者传递药物同时避免出现已知或怀疑由该药物引起的副作用的方法
US20220415464A1 (en) Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug
Adams et al. Pharmacists' Patient Care Process: a state “Scope of practice” perspective
Anagnostou Weighing the benefits and risks of oral immunotherapy in clinical practice
Alvaro‐Lozano et al. Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey
Sawangkum et al. Gestational weight gain: achieving a healthier weight between pregnancies
US7885824B1 (en) Method and system for delivering medical therapies
Howard-Ruben et al. Exploring novel approaches to food allergy management
Whitsel et al. Oral immunotherapy: The answer to peanut allergy?
Woodson et al. Multicentre study conducted across centres in the USA, Europe and Australia to assess the safety and effectiveness of a bilateral hypoglossal nerve stimulation system for the treatment of obstructive sleep apnoea in adults: a protocol for a pivotal, multicentre, open-label, single-arm study
Pepper et al. Emerging developments in the forefront of peanut oral immunotherapy
Rael Allergen immunotherapy
Stihl et al. Real life data with a six months follow-up from dietary interventions, biologic therapy and functional endoscopic surgery (FESS) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP)
Upton et al. Safety and Efficacy of Very Low‐Dose Multi‐Nut Oral Immunotherapy in Children
US20240029838A1 (en) Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
Schriefer et al. Medication reconciliation in the outpatient primary care setting: Barriers and opportunities
US20260083410A1 (en) Voice interrogation, control, and authentication of connected drug delivery devices
Weaver et al. Evaluation of appropriateness and cost savings of pharmacist-driven palivizumab ordering
Wang Mississippi